Futura specialises in the development and global commercialisation of innovative and proprietary sexual health products. Our lead product is Eroxon®, a clinically proven breakthrough treatment for erectile dysfunction (“ED”). Our purpose is to provide a range of clinically proven sexual health products that enhance quality of life.
Our strategy is to develop and commercialise innovative and clinically proven products for the OTC sexual health market. Our de-risked go-to-market strategy is to partner with leading consumer healthcare partners who are well resourced to commit significant marketing spend and expertise to engage effectively with consumers.
The Board has the overall responsibility to set the strategy for the Group and ensure that the Group delivers long term value to its shareholders.